Review: taking Fluconazole and Ranitidine together


Summary

Drug interactions are reported among people who take Fluconazole and Ranitidine together. This review analyzes the effectiveness and drug interactions between Fluconazole and Ranitidine. It is created by eHealthMe based on reports of 1,962 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Fluconazole and Ranitidine >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Fluconazole

Fluconazole has active ingredients of fluconazole. It is often used in preventive health care. (latest outcomes from Fluconazole 19,991 users)

Ranitidine

Ranitidine has active ingredients of ranitidine. It is often used in gastrooesophageal reflux disease. (latest outcomes from Ranitidine 33,438 users)

On Jul, 20, 2016

1,962 people who take Fluconazole, Ranitidine are studied.


Number of reports submitted per year:

Fluconazole and Ranitidine drug interactions.

Drug effectiveness over time:

Fluconazole:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 100.0% - (4 of 4 people)
  • 5 - 10 years: 100.0% - (4 of 4 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Ranitidine:
  • < 1 month: 0.0% - (0 of 3 people)
  • 1 - 6 months: 0.0% - (0 of 4 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 2 people)
  • 2 - 5 years: 100.0% - (4 of 4 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 50.0% - (1 of 2 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Fluconazole:
  • female: 91.0% - (11 of 12 people)
  • male: 0.0% - (0 of 1 people)
Ranitidine:
  • female: 38.0% - (5 of 13 people)
  • male: 0.0% - (0 of 3 people)

Drug effectiveness by age:

Fluconazole:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 100.0% - (5 of 5 people)
  • 50-59: 100.0% - (4 of 4 people)
  • 60+: 33.0% - (1 of 3 people)
Ranitidine:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 6 people)
  • 50-59: 100.0% - (5 of 5 people)
  • 60+: 0.0% - (0 of 4 people)

Most common drug interactions over time *:

< 1 month:
  • neutropenia
  • anaemia
  • pyrexia
  • leukopenia
  • febrile neutropenia
  • pneumonia
  • sepsis
  • hypotension
  • dehydration
  • hyperbilirubinaemia
1 - 6 months:
  • alanine aminotransferase increased
  • anaemia
  • aspartate aminotransferase increased
  • hepatic function abnormal
  • blood alkaline phosphatase increased
  • disseminated intravascular coagulation
  • thrombocytopenia
  • melaena
  • abdominal pain
  • enterococcal infection
6 - 12 months:
  • febrile neutropenia
  • septic shock
  • acute myeloid leukaemia
  • blood bilirubin increased
  • facial bones fracture
  • fall
  • hepatic function abnormal
  • herpes zoster
  • multiple myeloma
  • pulmonary infarction
1 - 2 years:
  • blood alkaline phosphatase increased
  • anaemia
  • blood lactate dehydrogenase increased
  • colonic polyp
  • enterocolitis
  • fracture
  • hyperlipidaemia
  • hyperuricaemia
  • osteopenia
  • pulmonary infarction
2 - 5 years:
  • depression
  • dry eyes
  • dry skin
  • hair loss
  • neuropathy peripheral
  • palpation
  • protein s increased
  • protein urine present
  • shortness of breath
  • weight loss
5 - 10 years:
  • asthma
  • multiple allergies
  • runny nose
  • aggression
  • agitation
  • amnesia
  • anger
  • anxiety
  • bipolar disorder
  • borderline personality disorder
10+ years:
  • amenorrhoea
  • anorexia
  • autoimmune hepatitis
  • cardiovascular disorder
  • chapped lips
  • dysphagia
  • fatigue
  • fibromyalgia
  • gastrointestinal disorder
  • gastrooesophageal reflux disease
not specified:
  • pyrexia
  • pain
  • nausea
  • anxiety
  • pneumonia
  • fatigue
  • anaemia
  • vomiting
  • dyspnoea
  • asthenia

Most common drug interactions by gender *:

female:
  • pain
  • pyrexia
  • oedema peripheral
  • asthenia
  • nausea
  • pneumonia
  • anxiety
  • hypokalaemia
  • back pain
  • vomiting
male:
  • pyrexia
  • pain
  • nausea
  • anaemia
  • pneumonia
  • neutropenia
  • fatigue
  • anxiety
  • injury
  • hypotension

Most common drug interactions by age *:

0-1:
  • tachycardia
  • pain
  • oxygen saturation decreased
  • pyrexia
  • rash
  • blister
  • hypotension
  • multi-organ failure
  • neonatal disorder
  • vomiting
2-9:
  • pyrexia
  • stevens johnson syndrome
  • cough
  • conjunctivitis
  • epidermal necrolysis
  • lung neoplasm
  • multi-organ failure
  • upper respiratory tract infection
  • blister
  • pharyngitis
10-19:
  • multi-organ failure
  • pyrexia
  • vomiting
  • hypotension
  • neutropenia
  • stevens johnson syndrome
  • corneal erosion
  • muscular weakness
  • febrile neutropenia
  • hypokalaemia
20-29:
  • pain
  • pain in extremity
  • asthenia
  • dizziness
  • pyelocaliectasis
  • dyspnoea
  • anxiety
  • headache
  • injury
  • cellulitis
30-39:
  • pyrexia
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • chest pain
  • diabetes mellitus
  • renal failure acute
  • blood alkaline phosphatase increased
  • blood bilirubin increased
  • dehydration
  • hypertension
40-49:
  • nausea
  • anaemia
  • fatigue
  • weight decreased
  • pneumonia
  • hyperlipidaemia
  • abdominal pain
  • dyspnoea
  • pain
  • gastrooesophageal reflux disease
50-59:
  • pneumonia
  • pyrexia
  • pain
  • fatigue
  • nausea
  • diarrhoea
  • decreased appetite
  • headache
  • hypoaesthesia
  • renal failure acute
60+:
  • pain
  • pyrexia
  • anxiety
  • anaemia
  • fatigue
  • bone disorder
  • anhedonia
  • asthenia
  • dyspnoea
  • pain in jaw

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Fluconazole and Ranitidine?

Can you answer these questions?

More questions for: Fluconazole, Ranitidine

You may be interested in these reviews

More reviews for: Fluconazole, Ranitidine

On eHealthMe, Fluconazole (fluconazole) is often used to treat preventive health care. Ranitidine (ranitidine) is often used to treat gastrooesophageal reflux disease. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.